| Literature DB >> 32342707 |
Abstract
Keywords: Companion diagnostics; Herceptest; complementary diagnostics; drug-diagnostic co-development; personalized medicine; precision medicine; regulatory requirements; trastuzumab
Year: 2020 PMID： 32342707 DOI： 10.1080/14737159.2020.1762573
Source DB: PubMed Journal: Expert Rev Mol Diagn ISSN： 1473-7159 Impact factor: 5.225